Tear Layer Lipid Thickness in Pterygium Patient Before and After Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02160769|
Recruitment Status : Recruiting
First Posted : June 11, 2014
Last Update Posted : April 18, 2018
The investigators study aims to capture the objective effects of pterygium surgery on tear layer lipid thickness and the tear layer.
Previous objective studies of the tear film has been limited to corneal staining grading, tear break up time and Schirmer's test which have been shown to poor to moderate repeatability. The effect of pterygiums on tear layer lipid thickness (LLT) has not previously been explored. With the LipiView Ocular Surface Interferometer, the investigators have the ability to assess the optical coherence interference pattern produced by light reflected off the tear film in a safe and non-invasive manner. Software analysis of the image then measures the tear LLT which can be used to objectively quantify the diagnosis of lipid-deficient dry eye.
|Condition or disease|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||80 participants|
|Official Title:||The Assessment of Tear Layer and Tear Layer Lipid Distribution Pre and 1 Month Post Pterygium Surgery Using a LipiView Ocular Surface Interferometer (LipiView)|
|Study Start Date :||November 2013|
|Estimated Primary Completion Date :||December 2019|
|Estimated Study Completion Date :||December 2019|
- tear lipid layer thickness [ Time Frame: 1 month ]An increase in tear lipid layer thickness 1 month post pterygium surgery in the operated eye
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02160769
|Contact: Cynthia Boo, Bsc||9820 email@example.com|
|Singapore Eye Research Institute||Recruiting|
|Singapore, Singapore., Singapore, 168751|
|Contact: Cynthia Boo 98206648 firstname.lastname@example.org|
|Principal Investigator: Louis Tong, PhD|